Novo Nordisk A/S (NVO) Gross Profit 2006–TTM

Name: Novo Nordisk A/S (NVO) gross profit history 2006-TTM
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-09-19

Novo Nordisk A/S annual gross profit for fiscal TTM was DKK 265.7 billion, an increase of 6.2% from DKK 250.3 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

NVO Annual Gross Profit

Gross Profit (annual)	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Gross Profit	DKK 265.7B	DKK 250.3B	DKK 245.9B	DKK 196.5B	DKK 148.5B	DKK 117.1B	DKK 106.0B	DKK 101.9B	DKK 94.2B	DKK 94.1B	DKK 94.6B	DKK 91.7B	DKK 74.2B	DKK 69.4B	DKK 64.6B	DKK 53.8B	DKK 49.1B	DKK 40.6B	DKK 35.5B	DKK 32.1B	DKK 29.2B

DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

NVO Quarterly Gross Profit

Gross Profit (quarterly)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Gross Profit	DKK 61.4B	DKK 83.2B	DKK 64.0B	DKK 57.1B	DKK 64.0B	DKK 65.2B	DKK 72.7B	DKK 60.0B	DKK 57.8B

DKK; DKKM / DKKB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Gross Profit at Comparable Companies

NVS Gross Profit — Novartis AG ADR
AZN Gross Profit — AstraZeneca PLC

More NVO metrics: Revenue · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding

All NVO financial statements → Interactive NVO charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.